Vip Patel

Array ( [id] => 1534237 [patent_doc_number] => 06489099 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-03 [patent_title] => 'Detection of DNA damaging agents' [patent_app_type] => B1 [patent_app_number] => 09/381989 [patent_app_country] => US [patent_app_date] => 2000-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 8883 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/489/06489099.pdf [firstpage_image] =>[orig_patent_app_number] => 09381989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4311689 [patent_doc_number] => 06242258 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-05 [patent_title] => 'Methods for the selective regulation of DNA and RNA transcription and translation by photoactivation' [patent_app_type] => 1 [patent_app_number] => 9/478092 [patent_app_country] => US [patent_app_date] => 2000-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9988 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/242/06242258.pdf [firstpage_image] =>[orig_patent_app_number] => 478092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1264191 [patent_doc_number] => 06660524 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-09 [patent_title] => 'Control of gene expression in eukaryotes' [patent_app_type] => B1 [patent_app_number] => 09/469211 [patent_app_country] => US [patent_app_date] => 1999-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 17730 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/660/06660524.pdf [firstpage_image] =>[orig_patent_app_number] => 09469211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636730 [patent_doc_number] => 06379925 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Angiogenic modulation by notch signal transduction' [patent_app_type] => B1 [patent_app_number] => 09/467997 [patent_app_country] => US [patent_app_date] => 1999-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 60 [patent_no_of_words] => 23257 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/379/06379925.pdf [firstpage_image] =>[orig_patent_app_number] => 09467997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4408538 [patent_doc_number] => 06232442 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-15 [patent_title] => 'Purified eukaryotic-initiation factor 4E having altered RNA binding affinity' [patent_app_type] => 1 [patent_app_number] => 9/465615 [patent_app_country] => US [patent_app_date] => 1999-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 7300 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/232/06232442.pdf [firstpage_image] =>[orig_patent_app_number] => 465615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 938364 [patent_doc_number] => 06972193 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-12-06 [patent_title] => 'Regulated transcription of targeted genes and other biological events' [patent_app_type] => utility [patent_app_number] => 09/466568 [patent_app_country] => US [patent_app_date] => 1999-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 37 [patent_no_of_words] => 32413 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/972/06972193.pdf [firstpage_image] =>[orig_patent_app_number] => 09466568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1559301 [patent_doc_number] => 06436639 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'Bak promoter expression system' [patent_app_type] => B1 [patent_app_number] => 09/367750 [patent_app_country] => US [patent_app_date] => 1999-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 39 [patent_no_of_words] => 12878 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/436/06436639.pdf [firstpage_image] =>[orig_patent_app_number] => 09367750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1068451 [patent_doc_number] => 06843996 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-01-18 [patent_title] => 'Immunogenic composition comprising an influenza virus with a temperature sensitive PB2 mutation' [patent_app_type] => utility [patent_app_number] => 09/452222 [patent_app_country] => US [patent_app_date] => 1999-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11389 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/843/06843996.pdf [firstpage_image] =>[orig_patent_app_number] => 09452222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1568000 [patent_doc_number] => 06376752 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-23 [patent_title] => 'Cytoplasmic inhibition of gene expression in a plant' [patent_app_type] => B1 [patent_app_number] => 09/436068 [patent_app_country] => US [patent_app_date] => 1999-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6798 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/376/06376752.pdf [firstpage_image] =>[orig_patent_app_number] => 09436068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4322778 [patent_doc_number] => 06331527 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-18 [patent_title] => 'Promoter smooth muscle cell expression' [patent_app_type] => 1 [patent_app_number] => 9/431349 [patent_app_country] => US [patent_app_date] => 1999-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 27 [patent_no_of_words] => 38274 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/331/06331527.pdf [firstpage_image] =>[orig_patent_app_number] => 431349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4349068 [patent_doc_number] => 06291211 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Promoter for smooth muscle cell expression' [patent_app_type] => 1 [patent_app_number] => 9/431414 [patent_app_country] => US [patent_app_date] => 1999-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 27 [patent_no_of_words] => 38285 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/291/06291211.pdf [firstpage_image] =>[orig_patent_app_number] => 431414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4420305 [patent_doc_number] => 06194559 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-27 [patent_title] => 'Abscisic acid responsive element-binding transcription factors' [patent_app_type] => 1 [patent_app_number] => 9/416050 [patent_app_country] => US [patent_app_date] => 1999-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 8494 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/194/06194559.pdf [firstpage_image] =>[orig_patent_app_number] => 416050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4123456 [patent_doc_number] => 06127132 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-03 [patent_title] => 'Phagemid library for antibody screening' [patent_app_type] => 1 [patent_app_number] => 9/414005 [patent_app_country] => US [patent_app_date] => 1999-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 5287 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/127/06127132.pdf [firstpage_image] =>[orig_patent_app_number] => 414005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 676775 [patent_doc_number] => RE039220 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2006-08-01 [patent_title] => 'Peptide-mediated gene transfer' [patent_app_type] => reissue [patent_app_number] => 09/404979 [patent_app_country] => US [patent_app_date] => 1999-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8363 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/039/RE039220.pdf [firstpage_image] =>[orig_patent_app_number] => 09404979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4308737 [patent_doc_number] => 06316224 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Chlorella virus promoters' [patent_app_type] => 1 [patent_app_number] => 9/400541 [patent_app_country] => US [patent_app_date] => 1999-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7748 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316224.pdf [firstpage_image] =>[orig_patent_app_number] => 400541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1021312 [patent_doc_number] => 06887699 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-03 [patent_title] => 'Recombinant negative strand RNA virus expression systems and vaccines' [patent_app_type] => utility [patent_app_number] => 09/396539 [patent_app_country] => US [patent_app_date] => 1999-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 42 [patent_no_of_words] => 31228 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/887/06887699.pdf [firstpage_image] =>[orig_patent_app_number] => 09396539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1458832 [patent_doc_number] => 06391572 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-21 [patent_title] => 'Methods for identifying modulators of transcriptional activator protein interactions' [patent_app_type] => B1 [patent_app_number] => 09/387418 [patent_app_country] => US [patent_app_date] => 1999-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 19 [patent_no_of_words] => 19104 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/391/06391572.pdf [firstpage_image] =>[orig_patent_app_number] => 09387418 [rel_patent_id] =>[rel_patent_doc_number] =>)